|
Volumn 56, Issue 1, 2011, Pages 164-167
|
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth
|
Author keywords
Neuroblastoma; Phase I; Relapse; Topoisomerase inhibitor
|
Indexed keywords
(3 IODOBENZYL)GUANIDINE;
ANTINEOPLASTIC AGENT;
BUSULFAN;
CYCLOPHOSPHAMIDE;
DNA TOPOISOMERASE;
FLUDARABINE;
GANGLIOSIDE GD2;
LINEZOLID;
N [2 [(4 HYDROXYPHENYL)AMINO] 3 PYRIDINYL] 4 METHOXYBENZENESULFONAMIDE;
QUINOXALINE DERIVATIVE;
THYMOCYTE ANTIBODY;
TOPOTECAN;
TYROSINE 3 MONOOXYGENASE;
UNCLASSIFIED DRUG;
XK 469;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BONE MARROW BIOPSY;
BONE SCINTISCANNING;
CANCER GROWTH;
CANCER INHIBITION;
CANCER RELAPSE;
CASE REPORT;
CATHETER INFECTION;
CELL CYCLE ARREST;
CELL CYCLE G2 PHASE;
CELL PROLIFERATION;
CELL SURVIVAL;
CELLULAR DISTRIBUTION;
CHILD;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
ENZYME INHIBITION;
FATIGUE;
FEMALE;
FEVER;
FLOW CYTOMETRY;
GRAFT REJECTION;
HIGH RISK PATIENT;
HUMAN;
IN VITRO STUDY;
LABORATORY TEST;
LYMPHOMA;
METASTASIS;
MONOTHERAPY;
MOUSE;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUROBLASTOMA;
NEUROBLASTOMA CELL;
NEUTROPENIA;
NONHUMAN;
PEPTOSTREPTOCOCCUS;
PRIORITY JOURNAL;
REDUCED INTENSITY CONDITIONING;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SCHOOL CHILD;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
TUMOR XENOGRAFT;
ADOLESCENT;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
FATAL OUTCOME;
HUMANS;
NEOPLASM METASTASIS;
NEUROBLASTOMA;
QUINOXALINES;
TREATMENT OUTCOME;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 78649638205
PISSN: 15455009
EISSN: 15455017
Source Type: Journal
DOI: 10.1002/pbc.22639 Document Type: Article |
Times cited : (20)
|
References (12)
|